Showing results (1561-1570 of 1,605) with videos related to

Sort By:
Pageof 161
JAMA Dermatology|October 29, 2025
HLA-B*58:01 and Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in the USChelsea N Campbell, Matthew S Krantz, Alexis Yu, et al.
JAMA Dermatology|October 22, 2025
T-Cell Receptor Clonotypes and Aggressive Subtypes in Cutaneous T-Cell LymphomaLiliana L Crisan, Shanpeng J Li, Michelle Afkhami, et al.
JAMA Dermatology|July 9, 2025
Ixekizumab and Malignant Neoplasms: A Pooled Analysis of Data From 25 Randomized Clinical TrialsJoseph F Merola, Kim A Papp, Atul Deodhar, et al.
JAMA Dermatology|September 12, 2025
Cutaneous Vasculitis in Primary Sjögren DiseasePaul Breillat, Véronique Le Guern, Thomas d'Humières, et al.
JAMA Dermatology|June 18, 2025
Psoriasis Risk in Patients With Atopic Dermatitis Treated With DupilumabTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
JAMA Dermatology|March 13, 2024
Prevalence and Patient Characteristics of Ectodermal Dysplasias in DenmarkLaura Krogh Herlin, Sigrun A J Schmidt, Xenia Buus Hermann, et al.
JAMA Dermatology|April 3, 2024
Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne TreatmentRonnie A Festok, Avni S Ahuja, Jared Y Chen, et al.
JAMA Dermatology|March 6, 2024
Symptoms of Cognitive Impairment Among Children With Atopic DermatitisEmily Z Ma, Hannah R Chang, Sarah Radtke, et al.
JAMA Dermatology|July 10, 2024
Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension StudyLisa A Beck, Robert Bissonnette, Mette Deleuran, et al.
JAMA Dermatology|July 17, 2024
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis UpdateAaron M Drucker, Megan Lam, David Prieto-Merino, et al.
Pageof 161